Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors
Clinical trial NCT07182435 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07182435
- Sponsor
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2028-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.